Stock Price
0.46
Daily Change
0 0%
Monthly
-8.00%
Yearly
360.00%
Q1 Forecast
0.40

Starpharma Holdings reported AUD10.83M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Medical Developments International AUD 21.57M 12.04M Dec/2025
Mesoblast USD 51.34M 38.14M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025